Literature DB >> 3203307

Ring formation and structural rearrangements of chromosome 1 as secondary changes in uterine leiomyomas with t(12;14)(q14-15;q23-24).

M Nilbert1, S Heim, N Mandahl, U M Flodérus, H Willén, M Akerman, F Mitelman.   

Abstract

Cytogenetic analysis of short-term cultures from two uterine leiomyomas revealed, in addition to the primary abnormality, the reciprocal translocation t(12;14)(q14-15;q23-24), secondary structural changes that in both cases included ring chromosomes and rearrangements of chromosome 1. One tumor had the karyotype 46,XX,r(1)(p34q32),ins(8;9)(q13;q13q22),t(12;14)(q14-15;q23- 24). Massive numerical rearrangements were found in the second leiomyoma, with chromosome numbers ranging from 47 to 92. In spite of this variability, two main cell populations could be discerned, one near-diploid, the other hypotetraploid, with most mitoses having chromosome numbers between 80 and 88. These findings were corroborated by flow cytometry, which revealed two peaks corresponding to DNA indexes of 0.97 and 1.77. The structural abnormalities t(1;1)(p31;q44) and t(12;14)(q14-15;q23-24) were present in all karyotypically abnormal cells, and one or more unidentified ring chromosomes were observed in most of the hypotetraploid mitoses. In no cells were double copies of the t(1;1) and t(12;14) rearrangements detected. The similarity between the secondary changes in the cases reported here suggests that clonal evolution in uterine leiomyoma is nonrandom.

Entities:  

Mesh:

Year:  1988        PMID: 3203307     DOI: 10.1016/0165-4608(88)90143-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas.

Authors:  M Nilbert; S Heim; N Mandahl; U M Flodérus; H Willén; F Mitelman
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

2.  An unusual karyotype in leiomyoma: Case report and literature review.

Authors:  Le Chang; Nagesh Rao; Nicholas Bernthal; Sarah M Dry; Aaron W James
Journal:  J Orthop       Date:  2015-11-02

3.  Molecular and clinicopathologic characterization of intravenous leiomyomatosis.

Authors:  Zehra Ordulu; Hongyan Chai; Gang Peng; Anna G McDonald; Michele De Nictolis; Eugenia Garcia-Fernandez; David Hardisson; Jaime Prat; Peining Li; Pei Hui; Esther Oliva; Natalia Buza
Journal:  Mod Pathol       Date:  2020-04-27       Impact factor: 7.842

4.  Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.

Authors:  Hanna-Riikka Heinonen; Annukka Pasanen; Oskari Heikinheimo; Tomas Tanskanen; Kimmo Palin; Jaana Tolvanen; Pia Vahteristo; Jari Sjöberg; Esa Pitkänen; Ralf Bützow; Netta Mäkinen; Lauri A Aaltonen
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.